Announced Wed, 23 Sept, 2026 · 18:45 IST

Trading Window Closed from Oct 1 for Q2 FY26 Results

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.6%Reaction day

₹252.00

prior close

₹256.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.5%-1.1% vs market

Pharmaceuticals peers, median of 172sector-1.0%-1.6% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.6-1.5-1.1-1.0-1.6

Next day

-4.8-1.2-3.6-0.8-4.0

-6.7-2.8-4.0-1.8-5.0

-2.8-1.8-1.0-1.4-1.4

-2.8-2.0-0.7-2.5-0.3

-3.3-3.3+0.0-3.0-0.3

-8.6-2.0-6.6-2.8-5.8

15d

-10.0-3.9-6.0-5.6-4.4

-8.3-10.7+2.4-9.7+1.3

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Auro Laboratories has closed its trading window from Oct 1, 2026 for all designated persons and their immediate relatives. The closure is ahead of the board considering unaudited financial results for Q2 and half year ending September 30, 2026. The window will reopen 48 hours after the results are made generally available.

Likely market impact

Routine insider trading compliance ahead of earnings; no direct impact on retail shareholders. Watch for Q2 FY26 results release.